The development of cancer diagnostic imaging and treatment is a major concern worldwide.
By integrating imaging and therapy into one theranostic nanoplatform for simultaneously …

With over 10 million new cases per year worldwide, cancer remains a difficult disease to
treat and a significant cause of morbidity and mortality. Over recent decades, there has been …

Nanotheranostics represents the next generation of medicine, fusing nanotechnology,
therapeutics, and diagnostics. By integrating therapeutic and imaging agents into one …

Nanomedicine is defined as “the application of nanotechnology to medicine, including the
use of nanometer-sized carrier materials for facilitating disease diagnosis, disease treatment …

Nanocarriers have great potential to enhance drug delivery efficiency and therapeutic effect
for various cancers. However, premature drug leakage and non-specific targeting still limit …

In recent years, the incidence and mortality rate of cancer is raising worldwide. Traditional
approaches for cancer patient management including surgery, chemotherapy, radiotherapy …

Cancer theranostics combines cancer diagnosis and cancer therapy, aiming for early
diagnosis, accurate molecular imaging, and precise treatment at the right timing and proper …

The incessant transitions occurring in a cancer cell in response to cancer therapy have put
forth a lot of irreversible consequences, eventuating a high mortality rate. This upsurge in …

Handbook of Nanomaterials for Cancer Theranostics focuses on recent developments in
advanced theranostic nanomedicines from a chemical and biological perspective where the …

Stimuli-activatable strategies prevail in the design of nanomedicine for cancer theranostics.
Upon exposure to endogenous/exogenous stimuli, the stimuli-activatable nanomedicine …